The COVID-19-induced sell-off has taken a toll on stocks across sectors. An analyst at Cantor Fitzgerald presented his take on how biotech investing could look after the coronavirus pandemic and …
More 10 Small-To-Mid-Cap Biotech Ideas For When The Coronavirus Fades Videos